42 University Hospital at Downstate Physicians Selected As “Top Doctors” By Leading Health Care Research And Ratings Company

Feb 15, 2019

BROOKLYN, NY – Forty-two University Hospital of Brooklyn physicians have been selected as “Top Doctors” by Castle Connolly Medical Ltd., a top health care resource and ratings company for health care consumers. To earn the title of Top Doctor, physicians must receive nominations by their peers and be vetted by the physician-led research team. Castle Connolly Top Doctors® are among the most highly sought-after medical professionals in their communities.

“I am proud 42 of our physicians were included in this coveted list as Castle Connolly Top Doctors,” said SUNY Downstate President Wayne J. Riley, M.D. “This designation reflects our commitment to delivering high quality patient care and safety with world class expertise in various health specialties right here in Brooklyn.” 

The 42 doctors from University Hospital of Brooklyn are:

  1. Ovadia Abulafia, MD Gynecologic Oncology
  2. Sanjeev Agarawal, MD MS Pain Medicine
  3. Michael Augenbraun, MD Infectious Disease
  4. David Biro, MD, PhD, FAAD Dermatology
  5. Jeffrey Birnbaum, MD Adolescent Medicine
  6. Jeffrey Borer, MD Cardiovascular Disease
  7. Erdal Cavusoglu, MD Interventional Cardiology
  8. Carl Cohen, MD Geriatric Psychiatry
  9. Jeremy Coplan, MD Psychiatry
  10. Howard Crystal, MD Neurology
  11. James Deutsch, MD Ophthalmology
  12. Stella Douros, MD Ophthalmology
  13. Lisa Dresner, MD, FACS Surgery
  14. Alan Feit, MD Cardiovascular Disease
  15. Sharon Glick, MD Dermatology
  16. Arthur Grant, MD, PhD Neurology
  17. Christina Guillen, MD Pediatrics
  18. Matthew Hanson, MD Otolaryngology
  19. Rosemary Jackson, MD Pediatrics
  20. Devon John, MD Surgery
  21. Rauno Joks, MD Allergy & Immunology
  22. Ewa Koziorynska, MD Neurology
  23. Jessica Krant, MD, MPH Dermatology
  24. Steven Levine, MD Neurology
  25. Mariana Markell, MD Nephrology
  26. Jonathan Marmur, MD, FACC, FACP Interventional Cardiology
  27. Simon Rabinowitz, MD, PhD, FAAP Pediatric Gastroenterology
  28. Richard Rosenfeld, MD Otolaryngology
  29. Moro Salifu, MD, MBA, MPH, MACP Nephrology
  30. David Schwartz, MD Radiation Oncology
  31. Steven Schwarz, MD Pediatric Gastroenterology
  32. Alexander Schwartzman, MD, MBA, FACS Surgery
  33. Iuliana Shapira, MD Medical Oncology
  34. Gurinder Sidhu, MD Medical Oncology
  35. Daniel Siegel, MD Dermatology
  36. Steven Simon, MD Dermatology
  37. Edward Smith, MD Ophthalmology
  38. Arnold Strashun, MD Nuclear Medicine
  39. William Urban, FAAOS MD Orthopedic Surgery
  40. Maria-Anna Vastardi, MD Allergy & Immunology
  41. Shivakumar Vignesh, MD Gastroenterology
  42. Ramaswamy Viswanathan, MD Psychiatry

For more information on Castle Connolly’s “Top Doctors,” click here.


About SUNY Downstate Health Sciences University

Downstate Health Sciences University in Brooklyn is one of four academic health centers (AMCs) in The State University of New York (SUNY) 64-campus system and the only SUNY AMC in New York City dedicated to health education, research, and patient care for the borough’s 2.7 million residents. Its flagship hospital, University Hospital at Downstate (UHD), is a teaching hospital and benefits from the expertise of Downstate’s exceptional medical school and world-class academic center research facilities. With a staff of over 800 physicians representing 53 specialties and subspecialties, Downstate offers comprehensive healthcare services to the community.

UHD provides high-risk neonatal and infant services, pediatric nephrology, and dialysis for kidney diseases and is the only kidney transplantation program in Brooklyn. Beyond its clinical expertise, Downstate houses a range of esteemed educational institutions, including its College of Medicine, College of Nursing, School of Health Professions, School of Graduate Studies, and School of Public Health. Downstate fosters innovation through its multifaceted biotechnology initiative, the Biotechnology Incubator and BioBAT, which support early-stage and more mature biotech companies.